Why Valeant Earnings Have Brought a New Multiyear Low for Investors
Over the past month, Valeant Pharmaceuticals sank to just above its 52-week low, but it appears that it has now been pushed over the edge with this most recent earnings report.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 188
Horizon Pharma Impresses With Q3 Earnings
Horizon Pharma PLC (NASDAQ: HZNP) reported its third-quarter financial results on Monday before the markets opened. The company said that it had $0.70 in earnings per share (EPS) and $208.7 million in revenue. There…
Americans Delay Medical Treatment to Avoid High Deductibles
A recent survey commissioned by Insurance.com found that almost two-thirds of respondents have delayed seeking medical care because of a high deductible.
Can Valeant Turn Itself Around With This Earnings Report?
Halfway through the third quarter, it looked like Joe Papa had really turned this company around, as Valeant Pharmaceuticals shares were up nearly double from their lows, but it has been a different story…
Concordia Disappoints on Earnings and Management Shift
Concordia International announced its third-quarter financial results before the markets opened on Monday, as well as a key change in leadership.
Why Ariad Pharma Earnings Are So Great Despite a Loss
Ariad Pharmaceuticals said it had a loss in the most recent quarter. However, incredibly positive growth for its flagship drug pulled this company through.
Why These 2 Biopharma Companies Are Running
Shares of Ionis Pharmaceuticals and Biogen were on the move Monday morning after the companies announced positive interim results from a late-stage trial.
Graphic Images on Cigarette Packages Could Save 650,000 Lives
A new study published in Tobacco Control indicates that including graphic images of the effects of smoking on the printed warning labels on cigarettes might save hundreds of thousands of lives.
How Analysts View Value and Opportunity in Gilead After Earnings
If you just looked at formal Buy and Sell ratings from Wall Street analysts, you might assume that everything is still fine and hopeful for Gilead Sciences.
11 Rules That Made The NFL Safer
Playing in the NFL is still terribly dangerous, with concussions which lead to brain damage likely the worst effect on players. Several NFL rules have increases the safety of the game. I list these…
Acceleron Pharma Rises Despite Q3 Revenue Miss
Acceleron Pharma released its third-quarter earnings report after the markets closed on Thursday, and shares rallied on Friday.
Regeneron Investors Cheer Q3 Earnings Beat, Eylea Growth
Regeneron Pharmaceuticals reported mixed third-quarter financial results before the markets opened on Friday.
Diplomat Pharmacy Tanks on Weak Earnings
Diplomat Pharmacy, Inc. (NYSE: DPLO) is one of the worst performing stocks in Thursday’s session. The company recently reported its third-quarter earnings which in turn cratered shares. The company said that it had $0.21…
Aurinia Pharmaceuticals Jumps on Phase 3 Trial Plans
Aurinia Pharmaceuticals shares saw a handy gain on Thursday morning after the company announced plans for a late-stage trial in the treatment of lupus nephritis.
Will Any Major Insurance Companies Offer ACA/Obamacare Plans After 2017?
Trying to look at the overall impact of the Affordable Care Act, or Obamacare, is something which may depend solely upon your income or your politics. The reality is that the view of this…